Purchase Order 75N94023P00817
Award Date
9/19/23
Potential Completion Date
9/18/24
Potential Value
$587K
Funding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Contracting Federal Agency
National Institute of Child Health and Human Development
Awardee
Bruker Biospin Corp
Ultimate Awardee
Bruker Corporation
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), awarded a firm-fixed price purchase order valued at approximately $1.2 million to Bruker Biospin Corp. to acquire upgrades to three nuclear magnetic resonance (NMR) spectrometer systems. The upgrades include the 500 MHz and 800 MHz NMR consoles and 900 MHz cryoplatform. The solicitation sought these upgrades to maintain high quality research capabilities at NIDDK....
The U.S. Department of Health and Human Services, National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $2,855,935.00 firm-fixed-price contract to Bruker Biospin Corp, a for-profit manufacturer, to provide five Avance Neo consoles for Bruker NMR spectrometers, a Q-band pulse 300 W amplifier for a Q-band pulsed EPR spectrometer, and two cryoplatforms for Bruker NMR spectrometers. This award supports upgrading the NMR and EPR...
This $1,526,289.00 firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Bruker Biospin Corp, a for-profit manufacturer, to provide an AVANCE NEO 500 MHz wide-bore nuclear magnetic resonance (NMR) spectrometer and associated hardware and software. The contract was awarded on July 10, 2019 with a completion date of October 14, 2020. This award was not set aside for a specific business...
This is a $477,127.70 firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a subsidiary of Bruker Corporation. The contract is for the AVANCE NEO 500 product, which is likely a specialized scientific instrument or equipment used to support NIDDK's medical research programs. The contract has an ultimate completion date of January 30, 2023 and was awarded on July 7, 2022. This contract was not set...
This purchase order award from the Department of Health and Human Services' National Institutes of Health to Bruker Biospin Corp. is for $209,888.76 to provide annual maintenance services for various Bruker NMR spectrometers and a CryoPlatform system located at the NIH campus in Bethesda, Maryland. The period of performance is from September 11, 2018 through September 16, 2019. The solicitation sought quotes for preventative maintenance from the original equipment manufacturer to support...
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $232,162.20 firm fixed price purchase order to Bruker Biospin Corp. to acquire a CryoPlatformTM Annual Maintenance Agreement. The agreement will provide maintenance and repair services for NMR systems, valued at approximately $15 million, used by NIDDK to conduct research gaining a fundamental understanding of protein structure and protein-protein as well as protein-drug interactions...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $541,469.31 firm fixed price purchase order to Bruker Biospin Corp., a subsidiary of Bruker Corporation, for the delivery and installation of a Bruker Avance NEO 600 MHz nuclear magnetic resonance spectrometer. The purchase order also requires Bruker Biospin Corp. to trade in outdated Bruker Biospin equipment for the new spectrometer. The period of...
The National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, awarded a $185,250 firm fixed-price purchase order to Bruker Biospin Corp, a for-profit manufacturer, for the delivery of a nuclear magnetic resonance (NMR) spectrometer. This award is not associated with any set-aside program. Bruker Biospin Corp is a subsidiary of the larger Bruker Corporation, which provides a wide range of analytical and detection equipment and services to various U.S. government...
This is a $216,140.00 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Bruker Biospin Corp, a wholly-owned subsidiary of Bruker Corporation. The contract is for the delivery of a MARIUS CLORE IN 5/B1-301ER 4118HVCF5L FLEXLINE CRYOGEN-FREE VTSYSTEM, which is a specialized nuclear magnetic resonance (NMR) spectrometer system. The award does not utilize any set-aside designations. Bruker Biospin Corp is an established...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $230,346.00 firm-fixed-price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments. The contract is for the provision of an NMR accessory MAS probe. The place of performance is Bethesda, Maryland. The contract does not have a set-aside designation. Bruker Biospin Corp is a subsidiary of the Bruker...